Product
Platinum based chemotherapy
Aliases
platinum based chemotherapy
Name
platinum based chemotherapy
5 clinical trials
3 drugs
7 indications
Indication
CancerIndication
Head and NeckIndication
Metastatic Non-small Cell Lung CancerIndication
Lung Cancer Stage IVIndication
Squamous Cell Carcinoma of Head and NeckIndication
Metastatic Squamous Cell CarcinomaIndication
Lung CancerDrug
CisplatinDrug
TQB2450Drug
mFOLFOX6Clinical trial
A Randomized, Double-Blind, Adaptive, Phase II/III Study of GSK3359609 in Combination With Pembrolizumab and 5FU-Platinum Chemotherapy Versus Placebo in Combination With Pembrolizumab Plus 5FU-Platinum Chemotherapy for First-Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaStatus: Terminated, Estimated PCD: 2021-04-27
Clinical trial
LUNAR-2: Pivotal, Randomized, Open-Label Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Pembrolizumab and Platinum-based Chemotherapy for the Treatment of Metastatic Non-Small Cell Lung CancerStatus: Not yet recruiting, Estimated PCD: 2028-10-01
Clinical trial
The Effect of Combined Cryotherapy and Immunotherapy on Systemic T Cell Changes and Clinical Outcomes in Metastatic Non-small Cell Lung CancerStatus: Recruiting, Estimated PCD: 2026-03-31
Clinical trial
A Phase IB Clinical Study of TBio-4101 (Autologous Selected and Expanded Tumor-Infiltrating Lymphocytes [TIL]) and Pembrolizumab With or Without Chemotherapy in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Cancer (HNSCC)Status: Recruiting, Estimated PCD: 2026-05-01
Clinical trial
A Randomized, Controlled, Multicenter Phase II Clinical Study Comparing Neoadjuvant Chemoimmunotherapy and Immuno-consolidationafter Compared With Immunoconsolidation After Radical Chemoradiotherapy for Stage III Potentially Resectable NSCLCStatus: Recruiting, Estimated PCD: 2027-05-19